Cargando…

METTL3 Facilitates Tumor Progression by COL12A1/MAPK Signaling Pathway in Esophageal Squamous Cell Carcinoma

Background: Esophageal squamous cell carcinoma (ESCC) is one of the most common aggressive tumors in the world. m6A modification has been implicated to play an important role in many biological progressions. METTL3 as the main methyltransferase has been found in many cancers, including ESCC. Here, w...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiali, Li, Zhenhua, Xu, Yanzhao, Huang, Chao, Shan, Baoen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2022
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990406/ https://www.ncbi.nlm.nih.gov/pubmed/35399719 http://dx.doi.org/10.7150/jca.66830

Ejemplares similares

Aprepitant inhibits the progression of esophageal squamous cancer by blocking the truncated neurokinin‑1 receptor
por: Zheng, Yang, et al.
Publicado: (2023)

B7‐H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin‐6/signal transducer and activator of transcription 3 pathway activation
por: Chen, Xinran, et al.
Publicado: (2016)

circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion
por: Gu, Lina, et al.
Publicado: (2022)

Upregulation of METTL3 Expression Predicts Poor Prognosis in Patients with Esophageal Squamous Cell Carcinoma
por: Xia, Tian-Liang, et al.
Publicado: (2020)

ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma
por: Li, Juan, et al.
Publicado: (2022)

Correction: circCYP24A1 facilitates esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-κB-induced CCL5 secretion
por: Gu, Lina, et al.
Publicado: (2023)

Increased B7-H4 expression during esophageal squamous cell carcinogenesis is associated with IL-6/STAT3 signaling pathway activation in mice
por: Chen, Xinran, et al.
Publicado: (2017)

MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway
por: Wang, Wei-Wei, et al.
Publicado: (2019)

METTL3 Is Associated With the Malignancy of Esophageal Squamous Cell Carcinoma and Serves as a Potential Immunotherapy Biomarker
por: Zhou, Yubin, et al.
Publicado: (2022)

MicroRNA-485-5p suppresses the progression of esophageal squamous cell carcinoma by targeting flotillin-1 and inhibits the epithelial-mesenchymal transition
por: Zhao, Riyang, et al.
Publicado: (2021)

USP36 facilitates esophageal squamous carcinoma progression via stabilizing YAP
por: Zhang, Wenhao, et al.
Publicado: (2022)

METTL3 Promotes Esophageal Squamous Cell Carcinoma Metastasis Through Enhancing GLS2 Expression
por: Chen, Xiaoting, et al.
Publicado: (2021)

A positive feedback between IDO1 metabolite and COL12A1 via MAPK pathway to promote gastric cancer metastasis
por: Xiang, Zhen, et al.
Publicado: (2019)

METTL3/m(6)A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma
por: Ge, Fangfang, et al.
Publicado: (2022)

Serum metabolomics analysis for the progression of esophageal squamous cell carcinoma
por: Li, Xia, et al.
Publicado: (2021)

Predictions for high COL1A1 and COL10A1 expression resulting in a poor prognosis in esophageal squamous cell carcinoma by bioinformatics analyses
por: Li, Yang, et al.
Publicado: (2020)

A cleaved METTL3 potentiates the METTL3–WTAP interaction and breast cancer progression
por: Yan, Chaojun, et al.
Publicado: (2023)

Overexpression of LRIG1 regulates PTEN via MAPK/MEK signaling pathway in esophageal squamous cell carcinoma
por: Jiang, Xiaofang, et al.
Publicado: (2016)

COL11A1 promotes esophageal squamous cell carcinoma proliferation and metastasis and is inversely regulated by miR-335-5p
por: Kang, Zheng, et al.
Publicado: (2021)

Upregulation of PEDF Predicts a Poor Prognosis and Promotes Esophageal Squamous Cell Carcinoma Progression by Modulating the MAPK/ERK Signaling Pathway
por: Chen, Zui, et al.
Publicado: (2021)

Cancer-Associated Fibroblasts Hinder Lung Squamous Cell Carcinoma Oxidative Stress-Induced Apoptosis via METTL3 Mediated m(6)A Methylation of COL10A1
por: Li, Yuchan, et al.
Publicado: (2022)

C12orf59 Promotes Esophageal Squamous Cell Carcinoma Progression via YAP-Mediated Epithelial-Mesenchymal Transition
por: Xu, Chunhua, et al.
Publicado: (2022)

Comparison of Up-Front Minimally Invasive Esophagectomy versus Open Esophagectomy on Quality of Life for Esophageal Squamous Cell Cancer
por: Li, Zhenhua, et al.
Publicado: (2021)

Upregulated METTL3 promotes metastasis of colorectal Cancer via miR-1246/SPRED2/MAPK signaling pathway
por: Peng, Wen, et al.
Publicado: (2019)

METTL3 Regulates Osteoblast Differentiation and Inflammatory Response via Smad Signaling and MAPK Signaling
por: Zhang, Yiwen, et al.
Publicado: (2019)

METTL3 facilitates tumor progression via an m(6)A-IGF2BP2-dependent mechanism in colorectal carcinoma
por: Li, Ting, et al.
Publicado: (2019)

RNF128 Promotes Invasion and Metastasis Via the EGFR/MAPK/MMP-2 Pathway in Esophageal Squamous Cell Carcinoma
por: Gao, Jing, et al.
Publicado: (2019)

METTL3-mediated m(6)A mRNA modification promotes esophageal cancer initiation and progression via Notch signaling pathway
por: Han, Hui, et al.
Publicado: (2021)

COL19A1 is a predictive biomarker for the responsiveness of esophageal squamous cell carcinoma patients to immune checkpoint therapy
por: Liu, Jian‐Hua, et al.
Publicado: (2023)

MicroRNA-181a-5p prevents the progression of esophageal squamous cell carcinoma in vivo and in vitro via the MEK1-mediated ERK-MMP signaling pathway
por: Wang, Mingbo, et al.
Publicado: (2022)

METTL3 Promotes the Progression of Gastric Cancer via Targeting the MYC Pathway
por: Yang, Dong-Dong, et al.
Publicado: (2020)

Exosomal lncRNA ZFAS1 regulates esophageal squamous cell carcinoma cell proliferation, invasion, migration and apoptosis via microRNA-124/STAT3 axis
por: Li, Zhirong, et al.
Publicado: (2019)

Contribution of KCTD12 to esophageal squamous cell carcinoma
por: Abbaszadegan, Mohammad Reza, et al.
Publicado: (2018)

Combination of the natural compound Periplocin and TRAIL induce esophageal squamous cell carcinoma apoptosis in vitro and in vivo: Implication in anticancer therapy
por: Han, Lujuan, et al.
Publicado: (2019)

RNA Editing Enzyme ADAR1 Regulates METTL3 in an Editing Dependent Manner to Promote Breast Cancer Progression via METTL3/ARHGAP5/YTHDF1 Axis
por: Li, Yi, et al.
Publicado: (2022)

Signatures within esophageal microbiota with progression of esophageal squamous cell carcinoma
por: Li, Minjuan, et al.
Publicado: (2020)

Corrigendum to ‘MicroRNA-134 prevents the progression of esophageal squamous cell carcinoma via the PLXNA1-mediated MAPK signalling pathway’ [EBioMedicine 46 (2019) 66–78]
por: Wang, Wei-Wei, et al.
Publicado: (2020)

Analysis of METTL3 and METTL14 in hepatocellular carcinoma
por: Liu, Xiangxiang, et al.
Publicado: (2020)

LSM12 facilitates the progression of colorectal cancer by activating the WNT/CTNNB1 signaling pathway
por: ZHUANG, YAN, et al.
Publicado: (2023)

Ezrin promotes esophageal squamous cell carcinoma progression via the Hippo signaling pathway
por: Ma, Lijuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v15apnls49kcnhh1fnct2f8n8v